Insider Buying: Hemab Therapeutics (NASDAQ:COAG) Major Shareholder Purchases 39,869 Shares of Stock

Posted by Jeff Wilder on May 11th, 2026

Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG – Get Free Report) major shareholder Ra Capital Management, L.P. bought 39,869 shares of the business’s stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $24.81 per share, for a total transaction of $989,149.89. Following the purchase, the insider directly owned 6,365,783 shares in the company, valued at approximately $157,935,076.23. This represents a 0.63% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Ra Capital Management, L.P. also recently made the following trade(s):

On Friday, May 8th, Ra Capital Management, L.P. acquired 1,483 shares of Hemab Therapeutics stock. The shares were bought at an average price of $24.98 per share, for a total transaction of $37,045.34.
On Thursday, May 7th, Ra Capital Management, L.P. acquired 9,906 shares of Hemab Therapeutics stock. The shares were bought at an average price of $24.46 per share, for a total transaction of $242,300.76.
On Wednesday, May 6th, Ra Capital Management, L.P. acquired 68,018 shares of Hemab Therapeutics stock. The shares were bought at an average price of $24.60 per share, for a total transaction of $1,673,242.80.
On Tuesday, May 5th, Ra Capital Management, L.P. acquired 97,411 shares of Hemab Therapeutics stock. The shares were bought at an average price of $24.63 per share, for a total transaction of $2,399,232.93.
On Monday, May 4th, Ra Capital Management, L.P. acquired 2,675,000 shares of Hemab Therapeutics stock. The shares were bought at an average price of $18.00 per share, for a total transaction of $48,150,000.00.

Hemab Therapeutics Trading Down 0.5%

Shares of Hemab Therapeutics stock traded down $0.12 on Monday, reaching $25.00. 239,335 shares of the company were exchanged, compared to its average volume of 376,423. Hemab Therapeutics Holdings, Inc. has a one year low of $23.00 and a one year high of $36.61.